These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 766682)

  • 21. Naringenin protects against isoniazid- and rifampicin-induced apoptosis in hepatic injury.
    Wang C; Fan RQ; Zhang YX; Nie H; Li K
    World J Gastroenterol; 2016 Nov; 22(44):9775-9783. PubMed ID: 27956801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for isoniazid (NIH)-induced liver dysfunction.
    Dickinson DS; Bailey WC; Hirschowitz BI; Soong SJ; Eidus L; Hodgkin MM
    J Clin Gastroenterol; 1981 Sep; 3(3):271-9. PubMed ID: 7288121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validity of serum glutamic oxalacetic transaminase determinations in isoniazid recipients.
    Bailey WC; Taylor SL; Samuels MS; Dascomb HE; Ziskind M; DeRouen TA
    Am Rev Respir Dis; 1973 Apr; 107(4):670-2. PubMed ID: 4697675
    [No Abstract]   [Full Text] [Related]  

  • 24. Elevated serum aminotransferase induced by isoniazid in relation to isoniazid acetylator phenotype.
    Yamamoto T; Suou T; Hirayama C
    Hepatology; 1986; 6(2):295-8. PubMed ID: 3957235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.
    Reynolds TB; Peters RL; Yamada S
    N Engl J Med; 1971 Oct; 285(15):813-20. PubMed ID: 4108110
    [No Abstract]   [Full Text] [Related]  

  • 26. Fatal hepatic necrosis due to isoniazid chemoprophylaxis in a 15-year-old girl.
    Vanderhoof JA; Ament ME
    J Pediatr; 1976 May; 88(5):867-8. PubMed ID: 1271153
    [No Abstract]   [Full Text] [Related]  

  • 27. Acetylation of acetylhydrazine, the toxic metabolite of isoniazid, in humans. Inhibition by concomitant administration of isoniazid.
    Peretti E; Karlaganis G; Lauterburg BH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):686-9. PubMed ID: 3681700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hepatotoxicity of isoniazid among the three acetylator phenotypes.
    Ellard GA; Girling DJ; Nunn AJ
    Am Rev Respir Dis; 1981 May; 123(5):568-70. PubMed ID: 7235381
    [No Abstract]   [Full Text] [Related]  

  • 29. Liver enzyme disturbances during isoniazid chemoprophylaxis in children.
    Beaudry PH; Brickman HF; Wise MB; MacDougall D
    Am Rev Respir Dis; 1974 Nov; 110(5):581-4. PubMed ID: 4429254
    [No Abstract]   [Full Text] [Related]  

  • 30. Monoacetylhydrazine as a metabolite of isoniazid in man.
    Timbrell JA; Wright JM; Baillie TA
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):602-8. PubMed ID: 913027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-acetyl transferase 2 and cytochrome P450 2E1 genes and isoniazid-induced hepatotoxicity in Brazilian patients.
    Santos NP; Callegari-Jacques SM; Ribeiro Dos Santos AK; Silva CA; Vallinoto AC; Fernandes DC; de Carvalho DC; Santos SE; Hutz MH
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):499-504. PubMed ID: 23394127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the role of acetylhydrazine in isoniazid hepatotoxicity.
    Timbrell JA
    Arch Toxicol Suppl; 1979; (2):1-8. PubMed ID: 288324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the effects of isoniazid on acetylhydrazine metabolism in vivo and in vitro.
    Timbrell JA; Wright JM
    Drug Metab Dispos; 1979; 7(4):237-40. PubMed ID: 39727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Close monitoring is essential during isoniazid prophylaxis.
    Atuk NO; Hart AD; Hunt EH
    South Med J; 1977 Feb; 70(2):156-9. PubMed ID: 841390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of oxygen free radicals in isoniazid-induced hepatotoxicity.
    Walubo A; Smith P; Folb PI
    Methods Find Exp Clin Pharmacol; 1998 Oct; 20(8):649-55. PubMed ID: 9922980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of isoniazid-metabolizing enzyme genotypes and isoniazid-induced hepatotoxicity in tuberculosis patients.
    Sotsuka T; Sasaki Y; Hirai S; Yamagishi F; Ueno K
    In Vivo; 2011; 25(5):803-12. PubMed ID: 21753138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoniazid-associated hepatitis--serum enzyme determinations and histologic features.
    Lewis JE; Mello P; Knauer CM
    West J Med; 1975 May; 122(5):371-6. PubMed ID: 1130028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure to demonstrate transformation of lymphocytes of patients with isoniazid-associated hepatitis.
    Dove JT; Chaparas SD; Hedrick SR
    Am Rev Respir Dis; 1972 Sep; 106(3):485-7. PubMed ID: 5080721
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti tubercular treatment induced hepatotoxicity: does acetylator status matter?
    Singh J; Garg PK; Thakur VS; Tandon RK
    Indian J Physiol Pharmacol; 1995 Jan; 39(1):43-6. PubMed ID: 7705868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: Disturbed hepatic function during isoniazid chemoprophylaxis.
    Levy SA
    Am Rev Respir Dis; 1973 Dec; 108(6):1452-3. PubMed ID: 4751738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.